Acceleron proposes follow-on

Acceleron Pharma Inc. (NASDAQ: XLRN), Cambridge, Mass. Business: Musculoskeletal, Hematology, Cancer Date announced: 1/9/14 Type: Follow-on To be raised: Up to $115 million Shares: TBD Price prior: $4...